Minnesota SF 2496: Cannabinoid products derived from industrial hemp sale authorization

Status: Referred to Health and Human Services Finance and Policy (as of 2019-03-14)

State: Minnesota · Session: 2019-2020 · Bill: SF 2496

Subjects: Commerce and Commerce Department, Drugs and Medicine, Health and Health Department

Sponsors: Bigham, Eaton, Frentz, Koran, Osmek

View Minnesota SF 2496 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.